Deborah Yoong1, Mark Naccarato2, Kevin Gough3, Jordan Lewis4, Ahmed M Bayoumi5. 1. Clinical Pharmacy Practitioner, St. Michael's Hospital, Toronto, ON. 2. Clinical Pharmacist, St. Michael's Hospital, Toronto, ON. 3. Head, Division of Infectious Diseases, Medical Director, HIV Service, St. Michael's Hospital/University of Toronto, Toronto, ON. 4. Social Worker, St. Michael's Hospital, Toronto, ON. 5. Associate Professor, Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON.
Abstract
BACKGROUND: Without a national pharmacare plan in Canada, HIV-infected patients across the nation differ in their ability to obtain essential HIV therapy. Despite the fact there are public insurance programs in Ontario, patients are unable to access medication. The authors described how frequently patients in their urban clinic could not access medications and why they required a compassionate supply of HIV drugs, with the goals of minimizing treatment delays and avoiding interruptions. METHODS: The authors conducted a retrospective review and collected information about demographic characteristics, current drug insurance and the challenges encountered. RESULTS: Over one year, the authors provided 2,886 days of free HIV drugs to 42 patients who were predominantly citizens or permanent residents of Canada (88%). The most common obstacles were associated with the Trillium Drug Program and the total value of all drugs supplied was $134,860. INTERPRETATION: This study suggests that Ontario's catastrophic drug insurance plan leaves some patients with significant gaps in drug coverage.
BACKGROUND: Without a national pharmacare plan in Canada, HIV-infectedpatients across the nation differ in their ability to obtain essential HIV therapy. Despite the fact there are public insurance programs in Ontario, patients are unable to access medication. The authors described how frequently patients in their urban clinic could not access medications and why they required a compassionate supply of HIV drugs, with the goals of minimizing treatment delays and avoiding interruptions. METHODS: The authors conducted a retrospective review and collected information about demographic characteristics, current drug insurance and the challenges encountered. RESULTS: Over one year, the authors provided 2,886 days of free HIV drugs to 42 patients who were predominantly citizens or permanent residents of Canada (88%). The most common obstacles were associated with the Trillium Drug Program and the total value of all drugs supplied was $134,860. INTERPRETATION: This study suggests that Ontario's catastrophic drug insurance plan leaves some patients with significant gaps in drug coverage.
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Niteesh K Choudhry; Jerry Avorn; Robert J Glynn; Elliott M Antman; Sebastian Schneeweiss; Michele Toscano; Lonny Reisman; Joaquim Fernandes; Claire Spettell; Joy L Lee; Raisa Levin; Troyen Brennan; William H Shrank Journal: N Engl J Med Date: 2011-11-14 Impact factor: 91.245
Authors: Sarah J Fielden; Melanie L A Rusch; Benita Yip; Evan Wood; Kate Shannon; Adrian R Levy; Julio S G Montaner; Robert S Hogg Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2008-09-23
Authors: Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2009-04-15 Impact factor: 3.731
Authors: Jean B Nachega; Rory Leisegang; David Bishai; Hoang Nguyen; Michael Hislop; Susan Cleary; Leon Regensberg; Gary Maartens Journal: Ann Intern Med Date: 2010-01-05 Impact factor: 25.391
Authors: Virginie Demers; Magda Melo; Cynthia Jackevicius; Jafna Cox; Dimitri Kalavrouziotis; Stéphane Rinfret; Karin H Humphries; Helen Johansen; Jack V Tu; Louise Pilote Journal: CMAJ Date: 2008-02-12 Impact factor: 8.262
Authors: Sylvie Boyer; Fabienne Marcellin; Pierre Ongolo-Zogo; Séverin-Cécile Abega; Robert Nantchouang; Bruno Spire; Jean-Paul Moatti Journal: Bull World Health Organ Date: 2009-04 Impact factor: 9.408